Cerulean Pharma reported $9.54M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Arrowhead Research ARWR:US $ 110.25M 19.49M
Bayer BAYN:GR 9.1B 154M
Brainstorm Cell Therapeutics BCLI:US $ 5.48M 737K
Cerulean Pharma CERU:US $ 9.54M 3.13M
Immunogen IMGN:US $ 60.93M 1.62M
Nektar Therapeutics NKTR:US $ 137.92M 598K